QRPH - Quality Outcome Reporting for EMS (QORE)
0.1.0 - ci-build International flag

QRPH - Quality Outcome Reporting for EMS (QORE), published by IHE Quality, Research and Public Health Committee. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IHE/QRPH.QORE/ and changes regularly. See the Directory of published versions

: Example of an Opioid measure - JSON Representation

Unknown as of 2024-10-23

Raw json | Download

{
  "resourceType" : "Measure",
  "id" : "example-IHE-QORE-Opioid-11",
  "meta" : {
    "security" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/v3-ActReason",
        "code" : "HTEST"
      }
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Measure example-IHE-QORE-Opioid-11</b></p><a name=\"example-IHE-QORE-Opioid-11\"> </a><a name=\"hcexample-IHE-QORE-Opioid-11\"> </a><a name=\"example-IHE-QORE-Opioid-11-en-US\"> </a><p><b>url</b>: <a href=\"Measure-example-IHE-QORE-Opioid-11.html\">Measure Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration</a></p><p><b>version</b>: 0.1.0</p><p><b>title</b>: Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration</p><p><b>status</b>: Unknown</p><p><b>date</b>: 2024-10-23 20:00:04+0000</p><p><b>publisher</b>: IHE Quality, Research and Public Health Committee</p><p><b>contact</b>: <a href=\"https://www.ihe.net/ihe_domains/quality_research_and_public_health/\">https://www.ihe.net/ihe_domains/quality_research_and_public_health/</a>, <a href=\"mailto:qrph@ihe.net\">qrph@ihe.net</a>, IHE Quality, Research and Public Health Committee: <a href=\"mailto:qrph@ihe.net\">qrph@ihe.net</a></p><p><b>jurisdiction</b>: <span title=\"Codes:{http://unstats.un.org/unsd/methods/m49/m49.htm 001}\">Global (Whole world)</span></p><p><b>copyright</b>: </p><div><p>IHE http://www.ihe.net/Governance/#Intellectual_Property</p>\n</div><p><b>type</b>: <span title=\"Codes:\">outcome</span></p><p><b>rationale</b>: </p><div><p>Patients an opioid overdose may become agitated or violent following naloxone administration due to acute opioid withdrawal. Therefore, the goal is to use the lowest dose possible to restore spontaneous respirations but avoid precipitating withdrawal</p>\n</div><p><b>definition</b>: </p><div><p>Measures the percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration.</p>\n</div><blockquote><p><b>group</b></p><blockquote><p><b>population</b></p><p><b>code</b>: <span title=\"Codes:\">numerator</span></p><p><b>description</b>: All patients who were given Narcan, and developed adverse effects.</p><h3>Criteria</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td>CQL</td></tr></table></blockquote><blockquote><p><b>population</b></p><p><b>code</b>: <span title=\"Codes:\">denominator</span></p><p><b>description</b>: All patients who were given Narcan.</p><h3>Criteria</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td>CQL</td></tr></table></blockquote></blockquote></div>"
  },
  "url" : "http://profiles.ihe.net/QRPH/QORE/Measure/example-IHE-QORE-Opioid-11",
  "version" : "0.1.0",
  "title" : "Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration",
  "status" : "unknown",
  "date" : "2024-10-23T20:00:04+00:00",
  "publisher" : "IHE Quality, Research and Public Health Committee",
  "contact" : [
    {
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://www.ihe.net/ihe_domains/quality_research_and_public_health/"
        }
      ]
    },
    {
      "telecom" : [
        {
          "system" : "email",
          "value" : "qrph@ihe.net"
        }
      ]
    },
    {
      "name" : "IHE Quality, Research and Public Health Committee",
      "telecom" : [
        {
          "system" : "email",
          "value" : "qrph@ihe.net"
        }
      ]
    }
  ],
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code" : "001"
        }
      ]
    }
  ],
  "copyright" : "IHE http://www.ihe.net/Governance/#Intellectual_Property",
  "type" : [
    {
      "coding" : [
        {
          "code" : "outcome"
        }
      ]
    }
  ],
  "rationale" : "Patients an opioid overdose may become agitated or violent following naloxone administration due to acute opioid withdrawal. Therefore, the goal is to use the lowest dose possible to restore spontaneous respirations but avoid precipitating withdrawal",
  "definition" : [
    "Measures the percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration."
  ],
  "group" : [
    {
      "population" : [
        {
          "code" : {
            "coding" : [
              {
                "code" : "numerator"
              }
            ]
          },
          "description" : "All patients who were given Narcan, and developed adverse effects.",
          "criteria" : {
            "language" : "text/cql"
          }
        },
        {
          "code" : {
            "coding" : [
              {
                "code" : "denominator"
              }
            ]
          },
          "description" : "All patients who were given Narcan.",
          "criteria" : {
            "language" : "text/cql"
          }
        }
      ]
    }
  ]
}